Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Asai

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Toxicology|October 18, 2021
Evaluation of the Expression Profile of Antibiotic-Induced Thrombocytopenia Using the Japanese Adverse Drug Event Report DatabaseYuki Asai, Takanori Yamamoto, Yasuharu Abe
Biological & Pharmaceutical Bulletin|April 4, 2022
The Effect of Single-Walled Carbon Nanotubes on UDP-Glucuronosyltransferase 1A Activity in Human LiverYuki Asai, Masayuki Nadai, Miki Katoh
Nanotechnology|July 9, 2016
Structural, optical, and transport properties of nanocrystalline bismuth telluride thin films treated with homogeneous electron beam irradiation and thermal annealingMasayuki Takashiri, Yuki Asai, Kazuki Yamauchi
Journal of Pharmacological Sciences|November 7, 2022
Distinct effects of orexin A on spontaneous and evoked synaptic currents in the rat nucleus tractus solitariusYoshiaki Ohi, Yuki Asai, Daisuke Kodama
Plos One|October 12, 2023
Effect of pharmacist-led intervention protocol on preventing postoperative delirium after elective cardiovascular surgeryYuki Asai, Tatsuki Yanagawa, Masaaki Takahashi
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 10, 2023
Risk evaluation of ampicillin/sulbactam-induced liver injury based on albumin-bilirubin scoreHayahide Ooi, Yuki Asai, Yoshiharu Sato
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 12, 2022
Risk assessment of micafungin-induced liver injury using spontaneous reporting system data and electronic medical recordsYuki Asai, Takanori Yamamoto, Yoshiharu Sato
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 13, 2023
Risk evaluation of carbapenem-induced liver injury based on machine learning analysisYuki Asai, Hayahide Ooi, Yoshiharu Sato
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Assessment of the risk of developing cefepime-induced abnormal liver enzyme levels using the albumin-bilirubin score and fibrosis-4 index: a single-centre retrospective case-control studyHiroki Katsu, Yuki Asai, Takuya Iwamoto, et al.
Drug Metabolism and Pharmacokinetics|November 22, 2017
Effect of carbamazepine on expression of UDP-glucuronosyltransferase 1A6 and 1A7 in rat brainYuki Asai, Yukiko Sakakibara, Masayuki Nadai, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Toxicology|October 18, 2021
Evaluation of the Expression Profile of Antibiotic-Induced Thrombocytopenia Using the Japanese Adverse Drug Event Report DatabaseYuki Asai, Takanori Yamamoto, Yasuharu Abe
Biological & Pharmaceutical Bulletin|April 4, 2022
The Effect of Single-Walled Carbon Nanotubes on UDP-Glucuronosyltransferase 1A Activity in Human LiverYuki Asai, Masayuki Nadai, Miki Katoh
Nanotechnology|July 9, 2016
Structural, optical, and transport properties of nanocrystalline bismuth telluride thin films treated with homogeneous electron beam irradiation and thermal annealingMasayuki Takashiri, Yuki Asai, Kazuki Yamauchi
Journal of Pharmacological Sciences|November 7, 2022
Distinct effects of orexin A on spontaneous and evoked synaptic currents in the rat nucleus tractus solitariusYoshiaki Ohi, Yuki Asai, Daisuke Kodama
Plos One|October 12, 2023
Effect of pharmacist-led intervention protocol on preventing postoperative delirium after elective cardiovascular surgeryYuki Asai, Tatsuki Yanagawa, Masaaki Takahashi
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 10, 2023
Risk evaluation of ampicillin/sulbactam-induced liver injury based on albumin-bilirubin scoreHayahide Ooi, Yuki Asai, Yoshiharu Sato
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 12, 2022
Risk assessment of micafungin-induced liver injury using spontaneous reporting system data and electronic medical recordsYuki Asai, Takanori Yamamoto, Yoshiharu Sato
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 13, 2023
Risk evaluation of carbapenem-induced liver injury based on machine learning analysisYuki Asai, Hayahide Ooi, Yoshiharu Sato
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Assessment of the risk of developing cefepime-induced abnormal liver enzyme levels using the albumin-bilirubin score and fibrosis-4 index: a single-centre retrospective case-control studyHiroki Katsu, Yuki Asai, Takuya Iwamoto, et al.
Drug Metabolism and Pharmacokinetics|November 22, 2017
Effect of carbamazepine on expression of UDP-glucuronosyltransferase 1A6 and 1A7 in rat brainYuki Asai, Yukiko Sakakibara, Masayuki Nadai, et al.
Pageof 6